New Investigator Program
Defining Vulvar Cancer Subtypes and Implications for Clinical Outcomes
Year Awarded:
2025
Human papillomavirus (HPV) is a common virus that can cause various health issues including certain cancers. Even with an established HPV vaccine, vaccination rates remain below the national average, putting people at risk for infections and related cancers. Particularly in the Midwest, disparities in race, ethnicity, rural or urban location and Medicaid status contribute to high rates of vulvar cancer nationally. This research aims to identify biomarkers of prognosis and treatment response for vulvar cancer, including the role of immune cells and their interactions with HPV in tumor tissues. The outcomes of this research will clarify and provide better treatment options for patients with vulvar and other HPV-related cancers.